Skip to main content
UniHealth

Doctor search

Flora Y Kim, NP

Nurse Practitioner · New York

NPI 1578930152

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2
Since medical school
11 years
Graduated 2015

Offices

2 locations · Trustees of Columbia University in the City of New York · Columbia Doctors of New Jersey P C

Looking this up.

Hospitals listed: New York-Presbyterian Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Flora Y Kim’s office to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • New York-Presbyterian HospitalNew York, NYAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of New York Presbyterian Healthcare System, which runs 8 hospitalsHome of Herbert Irving Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 72% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 15.2 (13.8 to 16.7) · 1,897 cases, Jan 2024 – Dec 2024Better than the national rate — Abdominopelvic accidental puncture or laceration rate: 0.35 (0 to 0.86) · 10,364 cases, Jul 2022 – Jun 2024Better than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.4 (0.3 to 0.51), Jul 2022 – Jun 2024Better than the national rate — In-hospital fall-associated fracture rate: 0.14 (0.03 to 0.25) · 52,654 cases, Jul 2022 – Jun 2024Better than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 1.48 (0.6 to 2.36) · 14,926 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative acute kidney injury requiring dialysis rate: 0.48 (0 to 1.06) · 8,078 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative hemorrhage or hematoma rate: 0.94 (0.21 to 1.66) · 12,529 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 6.15 (4.51 to 7.79) · 8,277 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 1.66 (0.42 to 2.91) · 8,436 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.09 (0 to 0.3) · 44,511 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.575, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.632, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.22, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.743, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.6 (2.9 to 4.4) · 1,897 cases, Jan 2024 – Dec 2024Better than the national rate — Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies): 10.6 (8.9 to 12.6) · 7,950 cases, Jan 2022 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.6 (0.6 to 0.7) · 4,225 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for New York-Presbyterian Hospital

Behind the star rating — Deaths: 6 better, 2 the same, 0 worse of 8 measures. Safety: 4 better, 4 the same, 0 worse of 8 measures. Readmissions: 3 better, 6 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at New York-Presbyterian Hospital
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits15.2 (13.8 to 16.7) · 1,897 casesWorseJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.35 (0 to 0.86) · 10,364 casesBetterJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.4 (0.3 to 0.51)BetterJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.14 (0.03 to 0.25) · 52,654 casesBetterJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths1.48 (0.6 to 2.36) · 14,926 casesBetterJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.48 (0 to 1.06) · 8,078 casesBetterJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths0.94 (0.21 to 1.66) · 12,529 casesBetterJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.15 (4.51 to 7.79) · 8,277 casesBetterJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths1.66 (0.42 to 2.91) · 8,436 casesBetterJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.09 (0 to 0.3) · 44,511 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.575BetterOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.632BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.22BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.743BetterOct 2024 – Sep 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits3.6 (2.9 to 4.4) · 1,897 casesBetterJan 2024 – Dec 2024
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits10.6 (8.9 to 12.6) · 7,950 casesBetterJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.6 (0.6 to 0.7) · 4,225 casesBetterJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths156.83 (135.92 to 177.74) · 798 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 382 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths5.7 · 574 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.6 · 616 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.9 · 2,532 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.9 · 3,140 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths7.7 · 1,821 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths1.8 · 24,470 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.11 (0 to 0.22) · 48,588 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths0.84 (0 to 1.9) · 3,187 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 1,240 casesNoneApr 2023 – Mar 2025
SSI - Abdominal HysterectomyInfections0.314No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.717No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.6 · 1,045 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.4 · 5,234 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits11 · 686 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits3 · 2,938 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits13.4 · 3,258 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.4 · 5,005 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.5 · 1,230 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.9 · 411 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.6 · 1,226 casesNoneJul 2023 – Jun 2025

What patients said (2,640 patients answered, 20% of those asked)

Patient survey stars by topic at New York-Presbyterian Hospital
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines3
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at New York-Presbyterian Hospital
Room was "always" clean65%
Nurses "always" communicated well76%
Doctors "always" communicated well78%
Staff "always" explained59%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge84%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully77%
Doctors "always" treated them with courtesy and respect84%
Patients who gave a rating of "9" or "10" (high)69%
Staff "always" explained new medications74%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully72%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night49%
"YES", patients would definitely recommend the hospital72%
Staff "always" explained possible side effects45%
Yes, staff "did" give patients information about possible symptoms87%

Original Medicare doctor bills

$6,554

Medicare paid this office $6,554 for 35 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)34$6,390$133

Who their Medicare patients are

35 Original Medicare patients in 2024. Average age 66 · 85 and older 0% · Women 57% · Health risk score 3.96. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Chronic kidney disease 74% · Diabetes 60% · COPD 51% · Coronary heart disease 43% · Atrial fibrillation 40% · Depression 31%.

The office billed $36,400, Medicare allowed $8,259 and paid $6,554; for 49 services of 2 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243549663.96$36,400$6,554
20234045715.77$14,256$4,255
20223032663.93$9,499$2,926
20183131712.10$4,163$2,621
20172424703.28$6,839$2,290
20161523633.29$8,985$2,441

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Original Medicare services billed in 2023
Long return visit (40+ min)38$4,121$98

2022: 1 service

Original Medicare services billed in 2022
Long return visit (40+ min)22$2,313$101

2018: 1 service

Original Medicare services billed in 2018
New patient visit (45+ min)17$1,666$98

2017: 1 service

Original Medicare services billed in 2017
Long return visit (40+ min)11$1,127$102

2016: 1 service

Original Medicare services billed in 2016
Long return visit (40+ min)15$2,360$107

Drugs they prescribed that Part D paid

$735,920

Pharmacies billed $735,920 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (23 of 1,866) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

1,528 generic and 231 brand-name prescriptions · $735,920 in drug cost · 271 antibiotic prescriptions to 74 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
PrevymisNone23$166,015$7,218
GammakedImmune globulin13$152,696$11,746
PrivigenImmune globulin12$57,126$4,760
PosaconazoleNone39$45,584$1,169
EliquisNone49$32,078$655
See all 41 drugs
Every Part D drug this clinician prescribed
PrevymisNone23$166,015$7,218
GammakedImmune globulin13$152,696$11,746
PrivigenImmune globulin12$57,126$4,760
PosaconazoleNone39$45,584$1,169
EliquisNone49$32,078$655
TacrolimusNone125$12,410$99
ValganciclovirNone44$11,497$261
OzempicNone11$10,215$929
AranespNone11$9,064$824
AtovaquoneNone18$6,203$345
Mycophenolic AcidNone13$4,251$327
Mycophenolate MofetilNone20$2,315$116
ValacyclovirNone29$1,527$53
AzithromycinNone81$1,157$14
PrednisoneNone98$944$10
MetoprololNone37$754$20
Sulfamethoxazole-TrimethoprimNone121$700$6
FamotidineNone63$639$10
Prenatal Vitamin Plus Low IronNone71$592$8
Ultra-Fine Short Pen NeedleNone11$578$53
OmeprazoleNone40$554$14
GabapentinNone57$551$10
AzathioprineNone23$547$24
LabetalolNone15$434$29
ClotrimazoleNone13$389$30
PantoprazoleNone22$380$17
Amlodipine BesylateNone40$254$6
AlendronateNone41$232$6
RosuvastatinNone24$222$9
AtorvastatinNone31$208$7
LevofloxacinNone25$153$6
SertralineNone18$146$8
Fludrocortisone AcetateNone12$142$12
ZolpidemNone18$126$7
OndansetronNone12$117$10
LosartanNone14$94$7
HydralazineNone12$86$7
Vitamin D2None14$50$4
AmoxicillinNone19$41$2
FurosemideNone14$38$3
MetoprololNone13$30$2

Year by year

Part D prescribing by year
20241,8661381% (23)12%$735,920
2023308102NoneNone$239,761
202221578None14%$169,156
202112646None10%$23,726
2020691452% (11)None$82,517
2019326140% (0)None$120,661
201829459NoneNone$102,409
20172,7431771% (14)14%$750,279
20162,9761822% (45)19%$960,168
201512040NoneNone$59,125

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Eliquis16$15,380$961
Valganciclovir14$4,490$321
Tacrolimus19$2,644$139
Prednisone25$132$5

2022: 3 drugs

Part D drugs prescribed in 2022
Gabapentin14$633$45
Azithromycin11$171$16
Prednisone11$67$6

2021: 2 drugs

Part D drugs prescribed in 2021
Pantoprazole19$189$10
Sulfamethoxazole-Trimethoprim12$40$3

2020: 14 drugs

Part D drugs prescribed in 2020
Valganciclovir51$30,246$593
Voriconazole25$12,869$515
Tacrolimus28$8,382$299
Itraconazole20$5,015$251
Enoxaparin12$3,319$277
Mycophenolate Mofetil13$1,572$121
Pantoprazole57$702$12
Nystatin22$628$29
Prednisone67$403$6
Sulfamethoxazole-Trimethoprim72$330$5
Gabapentin31$291$9
Metoprolol39$275$7
Furosemide25$108$4
Amlodipine Besylate17$47$3

2019: 9 drugs

Part D drugs prescribed in 2019
Valganciclovir42$39,279$935
Itraconazole28$25,117$897
Clotrimazole27$2,724$101
Tacrolimus16$696$44
Prednisone22$238$11
Pantoprazole44$195$4
Pravastatin11$161$15
Sulfamethoxazole-Trimethoprim34$88$3
Metoprolol13$45$3

2018: 7 drugs

Part D drugs prescribed in 2018
Valganciclovir25$27,549$1,102
Itraconazole11$11,750$1,068
Clotrimazole17$947$56
Pantoprazole21$249$12
Prednisone23$193$8
Sulfamethoxazole-Trimethoprim24$123$5
Metoprolol12$32$3

2017: 56 drugs

Part D drugs prescribed in 2017
ValganciclovirNone105$185,924$1,771
NoxafilNone21$117,615$5,601
CreonNone25$104,207$4,168
AtovaquoneNone31$49,527$1,598
PrivigenImmune globulin11$40,189$3,654
TacrolimusNone80$11,678$146
PrografNone12$10,098$841
UrsodiolNone27$8,796$326
NovologNone13$7,352$566
LyricaNone16$6,857$429
Mycophenolate MofetilNone53$5,936$112
EnoxaparinNone18$5,418$301
Esomeprazole MagnesiumNone33$4,751$144
Advair DiskusNone12$3,640$303
NexiumNone12$3,074$256
AzithromycinNone161$2,941$18
NystatinNone58$2,453$42
Cyclosporine ModifiedNone15$2,374$158
Omega-3 Acid Ethyl EstersNone19$2,159$114
MetoprololNone58$2,099$36
Potassium Citrate ErNone12$1,962$164
AzathioprineNone27$1,941$72
ClotrimazoleNone25$1,907$76
PrednisoneNone189$1,638$9
Sulfamethoxazole-TrimethoprimNone234$1,582$7
Humalog Kwikpen U-100None11$1,544$140
AcyclovirNone16$1,418$89
PravastatinNone70$1,405$20
GabapentinNone72$1,117$16
RosuvastatinNone15$1,112$74
PropranololNone43$969$23
OmeprazoleNone90$940$10
LevothyroxineNone53$919$17
DuloxetineNone22$894$41
AlendronateNone117$811$7
MetoprololNone87$699$8
AtorvastatinNone28$604$22
PantoprazoleNone27$465$17
Amlodipine BesylateNone42$464$11
Fluticasone PropionateNone24$461$19
Prenatal PlusNone17$441$26
TamsulosinNone20$347$17
HydralazineNone14$285$20
Prenatal Vitamin Plus Low IronNone45$283$6
Alcohol Prep PadsNone17$262$15
WarfarinNone14$256$18
LevofloxacinNone22$253$11
FamotidineNone35$229$7
ValacyclovirNone11$217$20
Sodium ChlorideNone19$211$11
Megestrol AcetateNone11$209$19
LosartanNone18$208$12
MirtazapineNone16$107$7
SertralineNone12$104$9
DiphenhydramineNone14$58$4
AmoxicillinNone15$28$2

2016: 66 drugs

Part D drugs prescribed in 2016
Noxafil31$174,662$5,634
Creon39$164,053$4,206
Valganciclovir68$124,892$1,837
Valcyte23$64,742$2,815
Atovaquone56$63,921$1,141
Tacrolimus92$12,866$140
Spiriva24$11,973$499
Advair Diskus38$11,195$295
Ursodiol42$10,553$251
Vancomycin12$8,724$727
Lyrica23$7,920$344
Enoxaparin14$7,580$541
Esomeprazole Magnesium27$5,645$209
Nexium16$5,371$336
Neoral12$5,108$426
Crestor20$5,026$251
Mycophenolate Mofetil60$4,926$82
Nystatin64$3,126$49
Clotrimazole26$2,606$100
Azithromycin115$2,407$21
Fluconazole17$2,068$122
Azathioprine21$1,825$87
Metoprolol44$1,519$35
Omeprazole137$1,334$10
Prednisone190$1,316$7
Warfarin44$1,291$29
Gabapentin101$1,160$11
Rosuvastatin13$1,123$86
Levothyroxine59$1,099$19
Propranolol41$1,092$27
Polyethylene Glycol 335012$1,092$91
Sulfamethoxazole-Trimethoprim168$1,049$6
Pravastatin51$1,026$20
Duloxetine18$934$52
Labetalol14$851$61
Levofloxacin43$845$20
Bd Ultra-Fine Pen Needle16$803$50
Alendronate119$740$6
Atorvastatin48$634$13
Valacyclovir18$573$32
Metoprolol73$537$7
Pantoprazole25$375$15
Tamsulosin21$369$18
Amlodipine Besylate48$339$7
Prenatal Plus13$332$26
Zolpidem14$270$19
Fluticasone Propionate17$221$13
Ondansetron24$221$9
Oxycodone12$216$18
Losartan24$206$9
Alcohol Prep Pads11$201$18
Fluoxetine23$200$9
Megestrol Acetate15$171$11
Escitalopram15$164$11
Sertraline15$157$10
Famotidine32$151$5
Prenatal Vitamin Plus Low Iron15$146$10
Klor-Con M2011$124$11
Amoxicillin-Clavulanate Potass11$124$11
Tramadol16$117$7
Simvastatin14$113$8
Mirtazapine25$112$4
Nizatidine11$112$10
Metoclopramide15$111$7
Furosemide17$76$4
Amoxicillin22$53$2

Money from drug and device companies

$65 in 2025

Industry payments by year
202522None$65
202425None$132
2023616None$482
202226None$131
202112None$248

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AbbvieCreon$35
1 payment
  • Meals for Creon · 2025-06-26 · $35
Astellas Pharma USCresemba$30
1 payment
  • Meals for Cresemba · 2025-10-09 · $30
See all 2 published payments
Every published payment
Astellas Pharma USMeals · 2025-10-09Cresemba$30
AbbvieMeals · 2025-06-26Creon$35
See earlier years (2024, 2023, 2022, 2021)

2024: $132

Payments by company in 2024
InsmedArikayce$104
4 payments
  • Meals for Arikayce · 2024-05-03 · $25
  • Meals for Arikayce · 2024-04-18 · $28
  • Meals for Arikayce · 2024-03-12 · $25
  • Meals for Arikayce · 2024-02-14 · $27
Boehringer Ingelheim PharmaceuticalsOfev$28
1 payment
  • Meals for Ofev · 2024-04-03 · $28

2023: $482

Payments by company in 2023
Boehringer Ingelheim PharmaceuticalsOfev$111
5 payments
  • Meals for Ofev · 2023-12-18 · $26
  • Meals for Ofev · 2023-09-18 · $19
  • Meals for Ofev · 2023-08-01 · $23
  • Meals for Ofev · 2023-06-29 · $22
  • Meals for Ofev · 2023-01-19 · $21
Astellas Pharma USCresemba$105
4 payments
  • Meals for Cresemba · 2023-07-10 · $33
  • Meals for Cresemba · 2023-04-17 · $26
  • Meals for Cresemba · 2023-03-07 · $24
  • Meals for Cresemba · 2023-01-30 · $23
AstraZeneca Pharmaceuticals LPTezspire$94
1 payment
  • Meals for Tezspire · 2023-02-16 · $94
InsmedArikayce$86
3 payments
  • Meals for Arikayce · 2023-04-28 · $29
  • Meals for Arikayce · 2023-04-05 · $31
  • Meals · 2023-03-09 · $27
Grifols USAProlastin-C Liquid$60
2 payments
  • Meals for Prolastin-C Liquid · 2023-05-09 · $27
  • Meals for Prolastin-C Liquid · 2023-03-06 · $33
Takeda Pharmaceuticals U.S.A.Livtencity$25
1 payment
  • Meals for Livtencity · 2023-04-24 · $25

2022: $131

Payments by company in 2022
Astellas Pharma USCresemba$86
4 payments
  • Meals for Cresemba · 2022-11-03 · $23
  • Meals for Cresemba · 2022-08-04 · $19
  • Meals for Cresemba · 2022-06-02 · $20
  • Meals for Cresemba · 2022-01-26 · $24
Boehringer Ingelheim PharmaceuticalsOfev$45
2 payments
  • Meals for Ofev · 2022-10-03 · $20
  • Meals for Ofev · 2022-01-18 · $25

2021: $248

Payments by company in 2021
AstraZeneca Pharmaceuticals LPBreztri$248
2 payments
  • Meals for Breztri · 2021-09-14 · $123
  • Meals for Breztri · 2021-02-11 · $125

Professional record

NPI
1578930152
Licence
CA 95006254, NY 430930
Group
Trustees of Columbia University in the City of New York · Columbia Doctors of New Jersey P C
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 363LA2100X (363LA2100X); Nurse practitioner (363L00000X)
Mailing address
630 W 168th St # 4, New York, NY, 10032
NPI first listed
2015-08-30
NPI last updated
2023-07-12
NPI record certified
2023-07-12

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305